Accéder au contenu
Merck

Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.

Bioorganic & medicinal chemistry letters (2006-01-24)
J I Levin, J M Chen, L M Laakso, M Du, J Schmid, W Xu, T Cummons, J Xu, G Jin, D Barone, J S Skotnicki
RÉSUMÉ

A series of thiomorpholine sulfonamide hydroxamate TACE inhibitors, all bearing propargylic ether P1' groups, was explored. In particular, compound 5h has excellent in vitro potency against isolated TACE enzyme and in cells, oral activity in a model of TNF-alpha production and a collagen-induced arthritis model, was selected as a clinical candidate for the treatment of RA.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Thiomorpholine, 98%